InvestorsHub Logo
Followers 31
Posts 6475
Boards Moderated 0
Alias Born 01/20/2016

Re: None

Saturday, 07/15/2017 12:15:00 PM

Saturday, July 15, 2017 12:15:00 PM

Post# of 463872
CNS Partnering---from the Anavex abstract----"The scientific rationale, preclinical data, and clinical development path of ANAVEX 2-73 as a novel treatment strategy for Rett Syndrome, Parkinson’s Disease, and Multiple Sclerosis will be discussed in more detail. This presentation will explore the links between preclinical findings and clinical trial development trajectory in our ongoing translational research efforts." anyone here care to comment ?? has progress been seen re:MS and Biogen's testing???? TIA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News